Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Treatment of colorectal cancer in older patients: International Society of Geriatric Oncology (SIOG) consensus recommendations 2013
Demetris Papamichael, Riccardo A. Audisio, Bengt Glimelius, et al.
Annals of Oncology (2014) Vol. 26, Iss. 3, pp. 463-476
Closed Access | Times Cited: 406

Showing 1-25 of 406 citing articles:

ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
Eric Van Cutsem, Andrés Cervantes, René Adam, et al.
Annals of Oncology (2016) Vol. 27, Iss. 8, pp. 1386-1422
Open Access | Times Cited: 3001
Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Rob Glynne‐Jones, Lucjan Wyrwicz, Emmanuel Tiret, et al.
Annals of Oncology (2017) Vol. 28, pp. iv22-iv40
Open Access | Times Cited: 1622
Colorectal cancer
Ernst J. Kuipers, William M. Grady, David A. Lieberman, et al.
Nature Reviews Disease Primers (2015) Vol. 1, Iss. 1
Open Access | Times Cited: 1275
Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Andrés Cervantes, R. Adam, Susana Roselló, et al.
Annals of Oncology (2022) Vol. 34, Iss. 1, pp. 10-32
Open Access | Times Cited: 887
Colorectal Cancer: A Review of Carcinogenesis, Global Epidemiology, Current Challenges, Risk Factors, Preventive and Treatment Strategies
Md. Sanower Hossain, Hidayah Karuniawati, Ammar Abdulrahman Jairoun, et al.
Cancers (2022) Vol. 14, Iss. 7, pp. 1732-1732
Open Access | Times Cited: 499
Herb and Spices in Colorectal Cancer Prevention and Treatment: A Narrative Review
Md. Sanower Hossain, Md. Abdul Kader, Khang Wen Goh, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 324
Systematic review of sarcopenia in patients operated on for gastrointestinal and hepatopancreatobiliary malignancies
Stef Levolger, Jeroen L.A. van Vugt, Ron W.F. de Bruin, et al.
British journal of surgery (2015) Vol. 102, Iss. 12, pp. 1448-1458
Open Access | Times Cited: 251
Prognostic Nutritional Index Predicts Severe Complications, Recurrence, and Poor Prognosis in Patients With Colorectal Cancer Undergoing Primary Tumor Resection
Ryuma Tokunaga, Yasuo Sakamoto, Shigeki Nakagawa, et al.
Diseases of the Colon & Rectum (2015) Vol. 58, Iss. 11, pp. 1048-1057
Closed Access | Times Cited: 235
Trends in colorectal cancer mortality in Europe: retrospective analysis of the WHO mortality database
Driss Ait Ouakrim, Cécile Pizot, Magali Boniol, et al.
BMJ (2015), pp. h4970-h4970
Open Access | Times Cited: 213
The impact of frailty on postoperative outcomes in individuals aged 65 and over undergoing elective surgery for colorectal cancer: A systematic review
Katleen Fagard, Silke Leonard, Mieke Deschodt, et al.
Journal of Geriatric Oncology (2016) Vol. 7, Iss. 6, pp. 479-491
Closed Access | Times Cited: 205
The effect of geriatric intervention in frail older patients receiving chemotherapy for colorectal cancer: a randomised trial (GERICO)
Cecilia Margareta Lund, Kirsten Vistisen, Anne Pries Olsen, et al.
British Journal of Cancer (2021) Vol. 124, Iss. 12, pp. 1949-1958
Open Access | Times Cited: 138
Prehabilitation versus no prehabilitation to improve functional capacity, reduce postoperative complications and improve quality of life in colorectal cancer surgery
Charlotte J. L. Molenaar, Stefan J van Rooijen, Hugo JP Fokkenrood, et al.
Cochrane library (2023) Vol. 2023, Iss. 6
Closed Access | Times Cited: 90
Personalized management of elderly patients with rectal cancer: Expert recommendations of the European Society of Surgical Oncology, European Society of Coloproctology, International Society of Geriatric Oncology, and American College of Surgeons Commission on Cancer
Isacco Montroni, Giampaolo Ugolini, Nicole M. Saur, et al.
European Journal of Surgical Oncology (2018) Vol. 44, Iss. 11, pp. 1685-1702
Open Access | Times Cited: 128
Surgical treatment and survival from colorectal cancer in Denmark, England, Norway, and Sweden: a population-based study
Sara Benítez Majano, Chiara Di Girolamo, Bernard Rachet, et al.
The Lancet Oncology (2018) Vol. 20, Iss. 1, pp. 74-87
Open Access | Times Cited: 125
The global challenge of colorectal cancer
Marianne G. Guren
˜The œLancet. Gastroenterology & hepatology (2019) Vol. 4, Iss. 12, pp. 894-895
Open Access | Times Cited: 100
Prognostic significance of preoperative prognostic nutritional index in colorectal cancer: results from a retrospective cohort study and a meta-analysis
Yuchong Yang, Peng Gao, Xiaowan Chen, et al.
Oncotarget (2016) Vol. 7, Iss. 36, pp. 58543-58552
Open Access | Times Cited: 93
Prehabilitation versus no prehabilitation to improve functional capacity, reduce postoperative complications and improve quality of life in colorectal cancer surgery
Charlotte J. L. Molenaar, Stefan J van Rooijen, Hugo JP Fokkenrood, et al.
Cochrane library (2022) Vol. 2022, Iss. 5
Open Access | Times Cited: 67
Lipid nanoparticle-based mRNA vaccines in cancers: Current advances and future prospects
Tao Huang, Lushan Peng, Yingying Han, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 52
Prognostic and therapeutic significance of a novel ferroptosis related signature in colorectal cancer patients
Songtao Du, Furong Zeng, Huiyan Sun, et al.
Bioengineered (2022) Vol. 13, Iss. 2, pp. 2498-2512
Open Access | Times Cited: 39
Surgery for T4 Colorectal Cancer in Older Patients: Determinants of Outcomes
Michael Osseis, William A Nehmeh, Nathalie Al Rassy, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 9, pp. 1534-1534
Open Access | Times Cited: 38
Oxaliplatin-Based Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 12 Trials
Claire Gallois, Qian Shi, Levi D. Pederson, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 19, pp. 2295-2305
Closed Access | Times Cited: 9
Soluble B7 and TNF family in colorectal cancer: Serum level, prognostic and treatment value
Mina Monfared, Sina Nazmi, Forough Parhizkar, et al.
Human Immunology (2025) Vol. 86, Iss. 2, pp. 111232-111232
Closed Access | Times Cited: 1
Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial—PRODIGE 20 study results
Thomas Aparicio, Olivier Bouché, Julien Taı̈eb, et al.
Annals of Oncology (2017) Vol. 29, Iss. 1, pp. 133-138
Open Access | Times Cited: 70
ECCO Essential Requirements for Quality Cancer Care: Colorectal Cancer. A critical review
Geerard L. Beets, David Sebag‐Montefiore, Elisabeth Andritsch, et al.
Critical Reviews in Oncology/Hematology (2016) Vol. 110, pp. 81-93
Open Access | Times Cited: 64
Reduced-dose combination chemotherapy (S-1 plus oxaliplatin) versus full-dose monotherapy (S-1) in older vulnerable patients with metastatic colorectal cancer (NORDIC9): a randomised, open-label phase 2 trial
Stine Brændegaard Winther, Gábor Liposits, Halla Skúladóttir, et al.
˜The œLancet. Gastroenterology & hepatology (2019) Vol. 4, Iss. 5, pp. 376-388
Closed Access | Times Cited: 55
Page 1 - Next Page

Scroll to top